Last Updated:
Name Designation Appointment Date Status
Stephen Maniachery Devassy

Appointed as Director since May 2018

Director 02-May-2018 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Grahams Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Mini Varghese

Appointed as Director since May 2018

Director 02-May-2018 Current
Lijo Baby

Appointed as Managing Director since May 2018

Managing Director 02-May-2018 Current
Lito Baby

Appointed as Director since May 2018

Director 02-May-2018 Current

People Timeline

Explore the timeline of key personnel in Grahams Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address 46/2373B, Chakkaraparambu Road, Kottankavu Junction, Vennala P O,, Cochin Kerala, 682028, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Grahams Pharmaceuticals Private Limited through their registered address at 46/2373B, Chakkaraparambu Road, Kottankavu Junction, Vennala P O,, Cochin Kerala, 682028, India, or via their website at grahamspharmaceuticals.com. Social media links are also provided where applicable.
The current directors of Grahams Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MINI VARGHESE
  • LIJO BABY
  • STEPHEN MANIACHERY DEVASSY
  • LITO BABY
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available